Stevanato Group (NYSE:STVN) Coverage Initiated by Analysts at Deutsche Bank Aktiengesellschaft

Stock analysts at Deutsche Bank Aktiengesellschaft assumed coverage on shares of Stevanato Group (NYSE:STVN) in a research report issued on Wednesday, Briefing.com reports. The brokerage set a “hold” rating on the stock.

A number of other research analysts have also issued reports on the company. Weiss Ratings raised Stevanato Group from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, August 27th. TD Cowen raised shares of Stevanato Group to a “strong-buy” rating in a research note on Wednesday, June 17th. Finally, UBS Group assumed coverage on shares of Stevanato Group in a research report on Wednesday, September 9th. They set a “neutral” rating and a $23.00 price objective for the company. Two analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy”.

Stevanato Group Stock Performance

Shares of STVN opened at €19.81 on Wednesday. Stevanato Group has a 12-month low of €12.89 and a 12-month high of €27.99. The company has a current ratio of 1.61, a quick ratio of 1.08 and a debt-to-equity ratio of 0.21. The firm has a market cap of $6.00 billion, a PE ratio of 35.37, a price-to-earnings-growth ratio of 1.64 and a beta of 0.78. The company’s 50 day simple moving average is €21.10 and its 200-day simple moving average is €18.55.

Stevanato Group (NYSE:STVN) last announced its earnings results on Wednesday, August 5th. The company reported €0.14 EPS for the quarter, missing analysts’ consensus estimates of €0.15 by (€0.01). The business had revenue of €302.00 million during the quarter. Stevanato Group had a net margin of 10.99% and a return on equity of 10.43%. As a group, equities analysts predict that Stevanato Group will post 0.69 EPS for the current year.

Insiders Place Their Bets

In related news, Director Elisabetta Magistretti sold 2,045 shares of the company’s stock in a transaction on Friday, August 7th. The stock was sold at an average price of €20.09, for a total transaction of €41,084.05. Following the transaction, the director owned 2,930 shares of the company’s stock, valued at €58,863.70. This represents a 41.11% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Luciano Santel sold 2,023 shares of the stock in a transaction on Friday, August 7th. The stock was sold at an average price of €20.09, for a total value of €40,642.07. Following the completion of the transaction, the director owned 4,739 shares of the company’s stock, valued at €95,206.51. The trade was a 29.92% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last quarter, insiders sold 21,926 shares of company stock valued at $459,738.

Hedge Funds Weigh In On Stevanato Group

A number of large investors have recently made changes to their positions in STVN. Wellington Management Group LLP purchased a new stake in Stevanato Group during the second quarter worth about $22,621,000. Ranger Investment Management L.P. purchased a new position in Stevanato Group in the second quarter valued at about $21,438,000. Conestoga Capital Advisors LLC lifted its position in shares of Stevanato Group by 7.6% during the 1st quarter. Conestoga Capital Advisors LLC now owns 8,491,751 shares of the company’s stock valued at $116,762,000 after acquiring an additional 602,050 shares during the period. Confluence Investment Management LLC purchased a new stake in shares of Stevanato Group during the 2nd quarter worth approximately $6,062,000. Finally, Roubaix Capital LLC grew its holdings in shares of Stevanato Group by 96.6% in the 1st quarter. Roubaix Capital LLC now owns 385,316 shares of the company’s stock worth $5,298,000 after acquiring an additional 189,343 shares during the period.

Stevanato Group Company Profile

Stevanato Group S.p.A. is an Italy-based provider of drug-containment, drug-delivery and diagnostic solutions for the pharmaceutical, biotechnology and healthcare industries. The company serves customers across the development, production and administration of injectable medicines, with activities spanning pharmaceutical glass packaging, medical devices and manufacturing technologies.

Its product portfolio includes glass vials, cartridges, syringes and other primary containers, as well as ready-to-use packaging solutions such as EZ-fill.